Protective effect of high mobility group box-1 silence on diabetic retinopathy: an in vivo study

被引:0
|
作者
Jiang, Ning [1 ]
Chen, Xiaolong [1 ]
机构
[1] China Med Univ, Shengjing Hosp, Dept Ophthalmol, 36 Sanhao St, Shenyang, Liaoning, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 2017年 / 10卷 / 08期
基金
中国国家自然科学基金;
关键词
High mobility group box-1; retinal endotheliocyte injury; high concentration of glucose; MAPK; NF-kappa B; diabetic retinopathy; ENDOTHELIAL GROWTH-FACTOR; THERAPEUTIC TARGET; RECEPTOR; 4; HMGB1; CELL; CONTRIBUTES; INHIBITION; DIFFERENTIATION; DYSFUNCTION; ACTIVATION;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To explore the effects of HMGB1 silence on cell apoptosis, inflammatory response and endothelial permeability barrier. Methods: Retinal tissues were isolated from 8 week-old SD rats and cells were cultured and identified. Effects of HMGB1 silence were detected by qRT-PCR and Western blot. Proliferation capability of cells was detected by MTT assay and LDH activity assays. Cell apoptosis was analyzed by flow cytometry, Hoechst staining and Caspase-3 activity assay. Furthermore, concentrations of VEGF, ICAM-1, VCAM-1, TNF-alpha and MCP-1 in the cell media were measured. Results: Results of our study showed that high concentration of glucose caused increased cell apoptosis and inflammatory response, and also influenced the endothelial permeability barrier. Whereas, these damaging effects of high concentration of glucose could be relieved by HMGB1 silence. Conclusion: The present study indicates that HMGB silence is a promising therapeutic option for diabetic retinopathy, and also provides theoretical basis for further exploration of diabetic retinopathy treatment.
引用
收藏
页码:8148 / 8160
页数:13
相关论文
共 50 条
  • [41] High Mobility Group Box-1 (HMGB1; Amphoterin) Is Required for Zebrafish Brain Development
    Zhao, Xiang
    Kuja-Panula, Juha
    Rouhiainen, Ari
    Chen, Yu-chia
    Panula, Pertti
    Rauvala, Heikki
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (26) : 23200 - 23213
  • [42] Anti-high mobility group box-1 antibody therapy for traumatic brain injury
    Okuma, Yu
    Liu, Keyue
    Wake, Hidenori
    Zhang, Jiyong
    Maruo, Tomoko
    Date, Isao
    Yoshino, Tadashi
    Ohtsuka, Aiji
    Otani, Naoki
    Tomura, Satoshi
    Shima, Katsuji
    Yamamoto, Yasuhiko
    Yamamoto, Hiroshi
    Takahashi, Hideo K.
    Mori, Shuji
    Nishibori, Masahiro
    ANNALS OF NEUROLOGY, 2012, 72 (03) : 373 - 384
  • [43] High-mobility group box-1 protein induces osteogenic phenotype changes in aortic valve interstitial cells
    Wang, Bo
    Li, Fei
    Zhang, Chao
    Wei, Guangxia
    Liao, Pingping
    Dong, Nianguo
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2016, 151 (01) : 255 - 262
  • [44] Human gingival fibroblasts release high-mobility group box-1 protein through active and passive pathways
    Feghali, K.
    Iwasaki, K.
    Tanaka, K.
    Komaki, M.
    Machigashira, M.
    Ishikawa, I.
    Izumi, Y.
    ORAL MICROBIOLOGY AND IMMUNOLOGY, 2009, 24 (04): : 292 - 298
  • [45] The box a domain of high mobility group box-1 protein as an efficient siRNA carrier with anti-inflammatory effects
    Lee, Sanghyun
    Song, Hojung
    Kim, Hyun Ah
    Oh, Binna
    Lee, Dong Yun
    Lee, Minhyung
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2012, 113 (01) : 122 - 131
  • [46] Relationship between plasma high mobility group box-1 protein levels and clinical outcomes of aneurysmal subarachnoid hemorrhage
    Zhu, Xiang-Dong
    Chen, Jing-Sen
    Zhou, Feng
    Liu, Qi-Chang
    Chen, Gao
    Zhang, Jian-Min
    JOURNAL OF NEUROINFLAMMATION, 2012, 9
  • [47] High-Mobility Group Box-1 Is Associated With Obesity, Inflammation, and Subclinical Cardiovascular Risk Among Young Adults A Longitudinal Cohort Study
    Chen, Li
    Zhu, Haidong
    Su, Shaoyong
    Harshfield, Gregory
    Sullivan, Jennifer
    Webb, Clinton
    Blumenthal, James A.
    Wang, Xiaoling
    Huang, Ying
    Treiber, Frank A.
    Kapuku, Gaston
    Li, Wenjun
    Dong, Yanbin
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2020, 40 (11) : 2776 - 2784
  • [48] Clinical Implication of the Relationship Between High Mobility Group Box-1 and Tumor Differentiation in Hepatocellular Carcinoma
    Ando, Kei
    Sakoda, Masahiko
    Ueno, Shinichi
    Hiwatashi, Kiyokazu
    Iino, Satoshi
    Minami, Koji
    Kawasaki, Yota
    Hashiguchi, Motoyuki
    Tanoue, Kiyonori
    Mataki, Yuko
    Kurahara, Hiroshi
    Maemura, Kosei
    Shinchi, Hiroyuki
    Natsugoe, Shoji
    ANTICANCER RESEARCH, 2018, 38 (06) : 3411 - 3418
  • [49] Blockade of high-mobility group box-1 ameliorates acute on chronic liver failure in rats
    Li, Xun
    Wang, Li-Kun
    Wang, Lu-Wen
    Han, Xiao-Qun
    Yang, Fan
    Gong, Zuo-Jiong
    INFLAMMATION RESEARCH, 2013, 62 (07) : 703 - 709
  • [50] A novel diagnostic tool for the detection of bladder cancer: Measurement of urinary high mobility group box-1
    Benlier, Necla
    Solakhan, Mehmet
    Yildirim, Zeliha
    Kaya, Vildan
    Yildirim, Omer Aydin
    Orhan, Nuri
    Cicek, Hulya
    Yildirim, Mustafa
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (08) : 685.e11 - 685.e16